Diagnosis and treatment of 2019 novel coronavirus infection in children: a pressing issue.
作者信息
Shen Kun-Ling, Yang Yong-Hong
机构信息
China National Clinical Research Center for Respiratory Diseases, Beijing, China.
Department of Respiratory Medicine, Beijing Children's Hospital, Capital Medical University, Beijing, China.
出版信息
World J Pediatr. 2020 Jun;16(3):219-221. doi: 10.1007/s12519-020-00344-6. Epub 2020 Feb 5.
Abstract
摘要
相似文献
1
Diagnosis and treatment of 2019 novel coronavirus infection in children: a pressing issue.儿童2019新型冠状病毒感染的诊断与治疗：一个紧迫的问题。
World J Pediatr. 2020 Jun;16(3):219-221. doi: 10.1007/s12519-020-00344-6. Epub 2020 Feb 5.
2
Epidemiology of Coronavirus Disease Outbreak: The Italian Trends.冠状病毒病疫情的流行病学：意大利的趋势
Rev Recent Clin Trials. 2020;15(2):87-92. doi: 10.2174/1574887115999200407143449.
3
A New Coronavirus Emerges, This Time Causing a Pandemic.一种新型冠状病毒出现了，这次引发了一场大流行。
Annu Rev Virol. 2020 Sep 29;7(1):iii-v. doi: 10.1146/annurev-vi-07-042020-100001.
4
Multicentre Italian study of SARS-CoV-2 infection in children and adolescents, preliminary data as at 10 April 2020.意大利多中心研究：2020 年 4 月 10 日之前 SARS-CoV-2 感染儿童和青少年的初步数据。
Euro Surveill. 2020 May;25(18). doi: 10.2807/1560-7917.ES.2020.25.18.2000600.
5
COVID-19 in Children: Clinical Approach and Management.儿童 COVID-19：临床方法与管理。
Indian J Pediatr. 2020 Jun;87(6):433-442. doi: 10.1007/s12098-020-03292-1. Epub 2020 Apr 27.
6
Studies on viral pneumonia related to novel coronavirus SARS-CoV-2, SARS-CoV, and MERS-CoV: a literature review.新型冠状病毒 SARS-CoV-2、SARS-CoV 和中东呼吸综合征冠状病毒（MERS-CoV）相关病毒性肺炎的研究：文献综述。
APMIS. 2020 Jun;128(6):423-432. doi: 10.1111/apm.13047.
7
Our recommendations for acute management of COVID-19.我们对新型冠状病毒肺炎急性处理的建议。
Crit Care. 2020 May 8;24(1):207. doi: 10.1186/s13054-020-02930-6.
8
COVID-19: Main therapeutic options.新型冠状病毒肺炎：主要治疗选择
Tunis Med. 2020 Apr;98(4):299-303.
9
COVID-19 epidemic: Disease characteristics in children.COVID-19 疫情：儿童疾病特征。
J Med Virol. 2020 Jul;92(7):747-754. doi: 10.1002/jmv.25807. Epub 2020 Apr 15.
10
Update on recommendations for the diagnosis and treatment of SARS-CoV-2 infection in children.儿童 SARS-CoV-2 感染诊断和治疗建议更新。
Eur J Clin Microbiol Infect Dis. 2020 Dec;39(12):2211-2223. doi: 10.1007/s10096-020-03973-x. Epub 2020 Aug 6.
引用本文的文献
1
Insights into biological therapeutic strategies for COVID-19.对新冠病毒病生物治疗策略的见解
Fundam Res. 2021 Mar;1(2):166-178. doi: 10.1016/j.fmre.2021.02.001. Epub 2021 Feb 4.
2
Pathogenic mechanisms of cardiovascular damage in COVID-19.COVID-19 中心血管损伤的发病机制。
Mol Med. 2024 Jun 19;30(1):92. doi: 10.1186/s10020-024-00855-2.
3
Clinical Course and Factors Associated With Hospital Admission and Mortality among Sars-Cov 2 Patients within Nairobi Metropolitan Area.内罗毕大都市区2019冠状病毒病患者的临床病程以及与住院和死亡相关的因素
medRxiv. 2024 May 15:2024.05.15.24307403. doi: 10.1101/2024.05.15.24307403.
4
"There is a strangeness in this disease": A qualitative study of parents' experiences caring for a child diagnosed with COVID-19.“这种疾病有些奇怪”：一项定性研究，探讨父母照顾 COVID-19 确诊儿童的经历。
PLoS One. 2024 Apr 2;19(4):e0300146. doi: 10.1371/journal.pone.0300146. eCollection 2024.
5
Immunomodulatory approaches in managing lung inflammation in COVID-19: A double-edge sword.管理 COVID-19 肺部炎症的免疫调节方法：一把双刃剑。
Immun Inflamm Dis. 2023 Sep;11(9):e1020. doi: 10.1002/iid3.1020.
6
Multidimensional futuristic approaches to address the pandemics beyond COVID-19.应对新冠疫情之外的大流行病的多维未来主义方法。
Heliyon. 2023 Jun;9(6):e17148. doi: 10.1016/j.heliyon.2023.e17148. Epub 2023 Jun 11.
7
An overview of key potential therapeutic strategies for combat in the COVID-19 battle.COVID-19战役中关键潜在治疗策略概述。
RSC Adv. 2020 Jul 28;10(47):28243-28266. doi: 10.1039/d0ra05434h. eCollection 2020 Jul 27.
8
COVID-19 features in children and adolescents: a systematic review and pooled analysis.儿童和青少年中的新冠病毒疾病特征：一项系统综述与汇总分析
EMBnet J. 2021 Jul;26. doi: 10.14806/ej.26.1.946. Epub 2021 Nov 26.
9
Clinical, laboratory and imaging characteristics, and outcomes of hospitalized children with suspected COVID-19 infection: A report from Isfahan-Iran.疑似新型冠状病毒肺炎感染住院儿童的临床、实验室及影像学特征与转归：来自伊朗伊斯法罕的报告
J Res Med Sci. 2022 Mar 17;27:27. doi: 10.4103/jrms.jrms_815_21. eCollection 2022.
10
Discriminant models for the prediction of postponed viral shedding time and disease progression in COVID-19.用于预测 COVID-19 病毒脱落时间延迟和疾病进展的判别模型。
BMC Infect Dis. 2022 Apr 11;22(1):366. doi: 10.1186/s12879-022-07338-x.
本文引用的文献
1
Middle East respiratory syndrome coronavirus in children.儿童中的中东呼吸综合征冠状病毒
Saudi Med J. 2015 Apr;36(4):484-6. doi: 10.15537/smj.2015.4.10243.
2
[Recombinant human interferon alpha 2b broad-spectrum anti-respiratory viruses pharmacodynamics study in vitro].重组人干扰素α2b体外抗呼吸道病毒广谱药效学研究
Yao Xue Xue Bao. 2014 Nov;49(11):1547-53.
3
[A field trial of recombinant human interferon alpha-2b for nasal spray to prevent SARS and other respiratory viral infections].重组人干扰素α-2b鼻喷雾剂预防SARS及其他呼吸道病毒感染的现场试验
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2005 Sep;19(3):216-9.
4
[Pay attention to severe acute respiratory syndrome].关注严重急性呼吸综合征
Zhonghua Er Ke Za Zhi. 2003 Jun;41(6):401-2.
5
[Clinical analysis of pediatric SARS cases in Beijing].[北京儿童非典病例的临床分析]
Zhonghua Er Ke Za Zhi. 2003 Aug;41(8):574-7.
6
Inhibition of respiratory virus infection by locally applied interferon.局部应用干扰素对呼吸道病毒感染的抑制作用
Lancet. 1973 Mar 17;1(7803):563-7. doi: 10.1016/s0140-6736(73)90714-9.
Zotero 插件